mTOR Signaling in Protein Translation Regulation: Implications in Cancer Genesis and Therapeutic Interventions

Mehvish Showkat1, Mushtaq A Beigh1, Khurshid I Andrabi1

  • 1Department of Biotechnology and Bioinformatics, University of Kashmir, Science Block, Ground Floor, Srinagar, Jammu and Kashmir 190006, India.

Insights

The mechanistic target of rapamycin (mTOR) pathway regulates cell growth and protein translation. Its dysregulation causes diseases like cancer, and drugs targeting mTOR show promise for treatment.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Biochemistry

Background:

  • The mechanistic target of rapamycin (mTOR) acts as a central nutrient sensor.
  • mTOR signaling regulates cellular energy substrates and protein translation.
  • Aberrant mTOR pathway activity is linked to various pathological conditions.

Purpose of the Study:

  • To review the physiological role of mTOR signaling in protein translation.
  • To explore the connection between translation dysregulation and diseases like cancer.
  • To discuss current therapeutic strategies targeting the mTOR pathway for cancer treatment.

Main Methods:

  • Literature review of mTOR signaling.
  • Analysis of data on protein translation dysregulation in pathology.
  • Survey of mTOR-targeting drugs for cancer therapy.

Main Results:

  • mTOR pathway is crucial for regulating protein synthesis and cell growth.
  • Dysregulated protein translation due to mTOR pathway abnormalities contributes to cancer development.
  • Targeting mTOR offers a viable strategy for cancer therapeutics.

Conclusions:

  • The mTOR pathway plays a critical role in cellular homeostasis and is implicated in disease pathogenesis.
  • Understanding mTOR-mediated translation control is key to developing effective cancer treatments.
  • Further research into mTOR inhibitors may yield novel therapeutic interventions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
11.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K